Cargando…

Proactive use of PROMs in ovarian cancer survivors: a systematic review

INTRODUCTION: The use of patient reported outcome measures (PROMs) has increased during the past decade, and the focus on how to use them has resulted in a more proactive application. Studies have shown that proactive use of PROMs during treatment improves patient-clinician communication, leads to b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kargo, Anette Stolberg, Coulter, Angela, Jensen, Pernille Tine, Steffensen, Karina Dahl
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631969/ https://www.ncbi.nlm.nih.gov/pubmed/31307510 http://dx.doi.org/10.1186/s13048-019-0538-9

Ejemplares similares

Are patient-reported outcomes useful in post-treatment follow-up care for women with early breast cancer? A scoping review
por: Riis, Cathrine Lundgaard, et al.
Publicado: (2019)

A catalogue of PROMs in sports science: Quality assessment of PROM development and validation
por: Hansen, Christian F., et al.
Publicado: (2021)

Shared decision making when patients consider surgery for lumbar herniated disc: development and test of a patient decision aid
por: Andersen, Stina Brogård, et al.
Publicado: (2019)

Shared decision making in recurrent ovarian cancer: Implementation of patient decision aids across three departments of oncology in Denmark
por: Wulff, Christian Nielsen, et al.
Publicado: (2022)

Implementing a PROACTive Care Pathway to Empower and Support Survivors of Breast Cancer
por: Franzoi, Maria Alice, et al.
Publicado: (2023)

Patient‐reported outcome measures ( PROMs): making sense of individual PROM scores and changes in PROM scores over time
por: van der Willik, Esmee M., et al.
Publicado: (2020)

Methodological Quality of PROMs in Psychosocial Consequences of Colorectal Cancer Screening: A Systematic Review
por: Gram, Emma Grundtvig, et al.
Publicado: (2023)

Immunohistochemical Expression of Platelet-Derived Growth Factor Receptors in Ovarian Cancer Patients with Long-Term Follow-Up
por: Madsen, Christine Vestergaard, et al.
Publicado: (2012)

PROM1 and PROM2 expression differentially modulates clinical prognosis of cancer: a multiomics analysis
por: Saha, Subbroto Kumar, et al.
Publicado: (2019)

Development, implementation and evaluation of patient decision aids supporting shared decision making in women with recurrent ovarian cancer
por: Hæe, Mette, et al.
Publicado: (2022)

Identification, description and appraisal of generic PROMs for primary care: a systematic review
por: Murphy, Mairead, et al.
Publicado: (2018)

A systematic review of patient-reported outcome measures (PROMs) in cystic fibrosis
por: Ratnayake, Irushi, et al.
Publicado: (2020)

Patient-reported outcome measures (PROMs) after laparoscopic cholecystectomy: systematic review
por: Melly, Conor, et al.
Publicado: (2022)

Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer
por: Steffensen, Karina Dahl, et al.
Publicado: (2011)

Ultra-short PROMs: clever or not?
por: Zimmermann, C
Publicado: (2010)

A systematic review and recommendations for prom instruments for older people with frailty in emergency care
por: van Oppen, James David, et al.
Publicado: (2022)

Measurement properties of patient-reported outcome measures (PROMs) in hyperhidrosis: a systematic review
por: Gabes, Michaela, et al.
Publicado: (2021)

Patient reported outcome measures (PROMS) for body image in dermatology: A systematic review
por: Kristensen, Johannes Kjeldstrup, et al.
Publicado: (2022)

Morbidity associated with "self-rated health" in epithelial ovarian cancer survivors
por: Liavaag, Astrid Helene, et al.
Publicado: (2009)

Shared decision making in high-grade glioma patients—a systematic review
por: Sorensen von Essen, Helle, et al.
Publicado: (2020)

Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer
por: Steffensen, Karina Dahl, et al.
Publicado: (2010)

Requirements for the collection of electronic PROMS either “in clinic” or “at home” as part of the PROMs, PREMs and Effectiveness Programme (PPEP) in Wales: a feasibility study using a generic PROM tool
por: O’Connell, Susan, et al.
Publicado: (2018)

Identification of high-risk patients by human epididymis protein 4 levels during follow-up of ovarian cancer
por: STEFFENSEN, KARINA DAHL, et al.
Publicado: (2016)

Systematic review of patient-reported outcome measures (PROMs) for assessing disease activity in rheumatoid arthritis
por: Hendrikx, Jos, et al.
Publicado: (2016)

Fusible PROM programmer 523017LE
por: Lienard, P
Publicado: (1978)

On the sensitivity of PROMs during breast radiotherapy
por: Heilemann, Gerd, et al.
Publicado: (2022)

Prognostic significance of baseline T cells, B cells and neutrophil-lymphocyte ratio (NLR) in recurrent ovarian cancer treated with chemotherapy
por: Henriksen, Jon Røikjær, et al.
Publicado: (2020)

Bringing Patient-Reported Outcome Measures (PROMs) Into Practice: A Review of the Latest Developments in PROM Use in the Evaluation and Treatment of Carpal Tunnel Syndrome
por: Chaudhury, Azraa S., et al.
Publicado: (2022)

Addressing Missing Data in Patient‐Reported Outcome Measures (PROMS): Implications for the Use of PROMS for Comparing Provider Performance
por: Gomes, Manuel, et al.
Publicado: (2015)

How to make PROMs work: qualitative insights from leaders at United States hospitals with successful PROMs programs
por: Hyland, Colby J., et al.
Publicado: (2023)

Prognostic Impact of Circulating Methylated Homeobox A9 DNA in Patients Undergoing Treatment for Recurrent Ovarian Cancer
por: Faaborg, Louise, et al.
Publicado: (2022)

Proactive control of proactive interference using the method of loci
por: Bass, Willa S., et al.
Publicado: (2014)

Single-cell and bulk RNA sequencing reveal ligands and receptors associated with worse overall survival in serous ovarian cancer
por: Carvalho, Robson Francisco, et al.
Publicado: (2022)

Acceptability of the method of administration of a patient-reported outcome measure (PROM) with stroke survivors, a randomised controlled trial protocol
por: Smith, Alexander, et al.
Publicado: (2018)

Uses and Abuses of Patient Reported Outcome Measures (PROMs): Potential Iatrogenic Impact of PROMs Implementation and How It Can Be Mitigated
por: Wolpert, Miranda
Publicado: (2013)

Use of patient-reported outcome measures (PROMs) in clinical diabetes consultations: the DiaPROM randomised controlled pilot trial
por: Hernar, Ingvild, et al.
Publicado: (2021)

Added value of patient-reported outcome measures (PROMs) after an acute stroke and early predictors of 90 days PROMs
por: Sanchez-Gavilan, Ester, et al.
Publicado: (2022)

Assessing the impact of headaches and the outcomes of treatment: A systematic review of patient-reported outcome measures (PROMs)
por: Haywood, Kirstie L, et al.
Publicado: (2017)

Measurement properties of patient-reported outcome measures (PROMs) in patients with hyperhidrosis: protocol for a systematic review
por: Gabes, Michaela, et al.
Publicado: (2021)

A multi-method approach to selecting PRO-CTCAE symptoms for patient-reported outcome in women with endometrial or ovarian cancer undergoing chemotherapy
por: Christiansen, Mille Guldager, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1lag5rgjka7ric6ipljp1ea3si